Phibro Animal Health (NASDAQ:PAHC) Stock Rating Upgraded by StockNews.com

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) was upgraded by StockNews.com from a "buy" rating to a "strong-buy" rating in a research report issued to clients and investors on Wednesday.

A number of other equities research analysts have also issued reports on the stock. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a report on Tuesday, December 17th. Barclays boosted their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $20.50.

Phibro Animal Health Stock Performance

Phibro Animal Health stock traded down $0.09 during mid-day trading on Wednesday, reaching $21.90. 99,351 shares of the company traded hands, compared to its average volume of 146,231. The company has a market capitalization of $887.02 million, a price-to-earnings ratio of 50.93, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health has a fifty-two week low of $10.03 and a fifty-two week high of $25.98. The firm's fifty day moving average is $22.08 and its two-hundred day moving average is $21.48.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.35 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.12. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. The firm had revenue of $260.40 million for the quarter, compared to analyst estimates of $277.76 million. During the same quarter in the prior year, the business earned $0.14 earnings per share. On average, equities research analysts expect that Phibro Animal Health will post 1.62 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC increased its stake in Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock valued at $11,430,000 after purchasing an additional 27,201 shares during the period. Barclays PLC increased its position in Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company's stock valued at $3,228,000 after acquiring an additional 29,271 shares during the period. Algert Global LLC raised its stake in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company's stock valued at $1,606,000 after acquiring an additional 59,850 shares during the last quarter. FMR LLC lifted its position in Phibro Animal Health by 22.7% during the 3rd quarter. FMR LLC now owns 39,310 shares of the company's stock worth $885,000 after acquiring an additional 7,270 shares during the period. Finally, BNP Paribas Financial Markets lifted its position in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock worth $548,000 after acquiring an additional 729 shares during the period. Hedge funds and other institutional investors own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.